NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Saniona AB (publ) (ST: SANION)
SANION Technical Analysis
1
As on 26th Jul 2024 SANION STOCK Price closed @ 4.40 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SANIONSTOCK Price
Open | 3.76 | Change | Price | % |
High | 4.49 | 1 Day | N/A | N/A |
Low | 3.76 | 1 Week | 0.00 | 0.00 |
Close | 4.40 | 1 Month | 0.00 | 0.00 |
Volume | 2037164 | 1 Year | 0.00 | 0.00 |
52 Week High 0.00 | 52 Week Low 0.00 |
ST Sweden Most Active Stocks
FING-B | 0.08 | % |
SAS | 0.02 | % |
LUNE | 21.97 | 6.65% |
SBB-B | 6.54 | % |
EURA | 0.14 | % |
HEXA-B | 107.25 | % |
TERRNT-B | 0.20 | % |
XBRANE | 0.25 | % |
NIBE-B | 45.93 | % |
BIOS | 0.02 | % |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
SANION Daily Charts |
SANION Intraday Charts |
Whats New @ Bazaartrend |
SANION Free Analysis |
|
SANION Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SANION Forecast July 2024
4th UP Forecast | 0 |
3rd UP Forecast | 0 |
2nd UP Forecast | 0 |
1st UP Forecast | 0 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | 0 |
4th DOWN Forecast | 0 |
SANION Weekly Forecast
4th UP Forecast | 0.00 |
3rd UP Forecast | 0.00 |
2nd UP Forecast | 0.00 |
1st UP Forecast | 0.00 |
1st DOWN Forecast | 0.00 |
2nd DOWN Forecast | 0.00 |
3rd DOWN Forecast | 0.00 |
4th DOWN Forecast | 0.00 |
SANION Forecast2024
4th UP Forecast | 0 |
3rd UP Forecast | 0 |
2nd UP Forecast | 0 |
1st UP Forecast | 0 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | 0 |
4th DOWN Forecast | 0 |
Saniona AB (publ) ( ST Sweden Symbol : SANION )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SANION Other Details
Segment | EQ | |
Market Capital | 697472128.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
SANION Address
![]() |
SANION Latest News
SANION Business Profile
Saniona AB (publ), a research and development company, engages in the development of drugs for diseases of the central nervous system and eating disorders in Denmark. The company's products include Tesofensine, a triple monoamine reuptake inhibitor; Tesomet, a fix-dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity; and CAD-1883 for movement disorders. It is also developing SAN711 for rare neuropathic disorders, which is in Phase 1; SAN903 that is in preclinical stage for rare inflammatory/fibrotic disorders; and Boehringer Ingelheim program for schizophrenia. In addition, it has a portfolio of various drug candidates in pre-clinical and clinical stages. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark. Address: Smedeland 26B, Glostrup, Denmark, 2600
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service